loading
前日終値:
$3.24
開ける:
$3.23
24時間の取引高:
420.86K
Relative Volume:
0.54
時価総額:
$616.72M
収益:
$12.99M
当期純損益:
$-74.39M
株価収益率:
-7.3182
EPS:
-0.44
ネットキャッシュフロー:
$-78.92M
1週間 パフォーマンス:
+2.88%
1か月 パフォーマンス:
-3.59%
6か月 パフォーマンス:
-3.01%
1年 パフォーマンス:
-17.86%
1日の値動き範囲:
Value
$3.195
$3.26
1週間の範囲:
Value
$3.11
$3.30
52週間の値動き範囲:
Value
$2.705
$4.725

Arbutus Biopharma Corp Stock (ABUS) Company Profile

Name
名前
Arbutus Biopharma Corp
Name
セクター
Healthcare (1164)
Name
電話
604-419-3200
Name
住所
701 VETERANS CIRCLE, WARMINSTER, PA
Name
職員
44
Name
Twitter
@arbutusbio
Name
次回の収益日
2025-03-26
Name
最新のSEC提出書
Name
ABUS's Discussions on Twitter

ABUS を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ABUS
Arbutus Biopharma Corp
3.22 620.55M 12.99M -74.39M -78.92M -0.44
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Arbutus Biopharma Corp Stock (ABUS) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2022-02-02 アップグレード Jefferies Hold → Buy
2021-02-25 開始されました Jefferies Hold
2020-12-17 開始されました H.C. Wainwright Buy
2020-07-27 再開されました JMP Securities Mkt Outperform
2020-07-24 ダウングレード Robert W. Baird Outperform → Neutral
2020-05-19 アップグレード Wedbush Neutral → Outperform
2020-03-06 アップグレード Chardan Capital Markets Neutral → Buy
2020-02-20 開始されました Robert W. Baird Outperform
2020-02-05 アップグレード JMP Securities Mkt Perform → Mkt Outperform
2019-10-07 繰り返されました B. Riley FBR Buy
2019-10-04 ダウングレード Chardan Capital Markets Buy → Neutral
2018-10-16 アップグレード B. Riley FBR Neutral → Buy
2018-10-15 アップグレード Wedbush Underperform → Neutral
2018-10-12 繰り返されました Chardan Capital Markets Buy
2018-07-06 ダウングレード B. Riley FBR, Inc. Buy → Neutral
2018-03-19 再開されました Chardan Capital Markets Buy
2018-03-19 ダウングレード Wedbush Outperform → Neutral
2018-01-05 開始されました B. Riley FBR, Inc. Buy
2017-04-04 アップグレード Chardan Capital Markets Neutral → Buy
2017-02-01 繰り返されました Wedbush Outperform
2016-12-13 ダウングレード Chardan Capital Markets Buy → Neutral
2016-11-30 アップグレード Chardan Capital Markets Neutral → Buy
すべてを表示

Arbutus Biopharma Corp (ABUS) 最新ニュース

pulisher
Jul 24, 2025

Is Arbutus Biopharma Corporation a good long term investmentMassive wealth growth - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 22, 2025

What analysts say about Arbutus Biopharma Corporation stockSuperior returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Arbutus Biopharma Corporation (NASDAQ:ABUS) Position Cut by Teacher Retirement System of Texas - Defense World

Jul 21, 2025
pulisher
Jul 20, 2025

What drives Arbutus Biopharma Corporation stock priceSuperior stock growth - Autocar Professional

Jul 20, 2025
pulisher
Jul 19, 2025

Arbutus Biopharma Corporation Stock Analysis and ForecastDynamic profit opportunities - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

What risks could impact Arbutus Biopharma Corporation stock performanceWealth Building Stock Portfolio - beatles.ru

Jul 18, 2025
pulisher
Jul 15, 2025

Why Arbutus Biopharma Corporation stock attracts strong analyst attentionBreakout Confirmation Tool - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Arbutus Biopharma Corporation stock price move sharplyFree Deep Market Trend Analysis - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Arbutus Biopharma Corporation stock performs during market volatilityFree Daily Stock Market Updates - Newser

Jul 15, 2025
pulisher
Jun 26, 2025

Warminster Biopharma Firm Ends $285M Licensing Deal with Chinese Company - BUCKSCO.Today

Jun 26, 2025
pulisher
Jun 25, 2025

Arbutus Biopharma (ABUS) Reacquires China Rights to Lead Drug | - GuruFocus

Jun 25, 2025
pulisher
Jun 25, 2025

Arbutus Reacquires Greater China Rights to Imdusiran and - GlobeNewswire

Jun 25, 2025
pulisher
Jun 13, 2025

Arbutus Biopharma Co. (NASDAQ:ABUS) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World

Jun 13, 2025
pulisher
Jun 08, 2025

Ameriprise Financial Inc. Makes New $62,000 Investment in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Jun 08, 2025
pulisher
Jun 07, 2025

Bank of America Corp DE Acquires 171,906 Shares of Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Jun 07, 2025
pulisher
Jun 05, 2025

Millennium Management LLC Purchases 92,068 Shares of Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Jun 05, 2025
pulisher
May 29, 2025

Deutsche Bank AG Buys 75,212 Shares of Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

May 29, 2025
pulisher
May 22, 2025

Northern Trust Corp Has $4.35 Million Holdings in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

May 22, 2025
pulisher
May 18, 2025

Arbutus Biopharma Reports Q1 2025 Results, Clinical Developments, and Legal Progress - MyChesCo

May 18, 2025
pulisher
May 18, 2025

Mercer Global Advisors Inc. ADV Makes New Investment in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

May 18, 2025
pulisher
May 18, 2025

Arbutus Biopharma Co. (NASDAQ:ABUS) Stake Boosted by Price T Rowe Associates Inc. MD - Defense World

May 18, 2025
pulisher
May 15, 2025

Arbutus: Q1 Earnings Snapshot - CT Insider

May 15, 2025
pulisher
May 14, 2025

Arbutus Biopharma Corp Reports Q1 2025 Earnings: Revenue at $1.8 Million, EPS Misses Estimate with $0.13 Loss - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Arbutus Biopharma earnings missed by $0.03, revenue fell short of estimates - Investing.com Canada

May 14, 2025
pulisher
May 14, 2025

Arbutus Biopharma (ABUS) Reports Mixed Q1 Results - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Arbutus Biopharma (ABUS) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 14, 2025
pulisher
May 14, 2025

Arbutus (ABUS) Reports Lower Q1 Revenue Amid Promising Treatment Progress | ABUS Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Arbutus Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire

May 14, 2025
pulisher
May 13, 2025

Is Editas Medicine (EDIT) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

May 13, 2025
pulisher
May 10, 2025

Arbutus Biopharma Showcases Promising Results for Hepatitis B Therapies at EASL Congress 2025 - MyChesCo

May 10, 2025
pulisher
May 08, 2025

Wells Fargo & Company MN Acquires 21,768 Shares of Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

May 08, 2025
pulisher
May 07, 2025

Arbutus Biopharma (ABUS) Showcases Promising Data on Imdusiran and AB-101 | ABUS Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Arbutus Presents Clinical Trial Data from its Two HBV Assets, Imdusiran and AB-101, at the European Association for the Study of the Liver (EASL) Congress 2025 - GlobeNewswire

May 07, 2025
pulisher
May 07, 2025

Arbutus Presents Clinical Trial Data from its Two HBV - GlobeNewswire

May 07, 2025
pulisher
May 06, 2025

Arbutus Biopharma Co. (NASDAQ:ABUS) Shares Purchased by Barclays PLC - Defense World

May 06, 2025
pulisher
May 05, 2025

Invesco Ltd. Grows Position in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

May 05, 2025
pulisher
May 02, 2025

Arbutus Biopharma Corp (ABUS) is a good investment, but the stock may be overvalued - uspostnews.com

May 02, 2025
pulisher
May 01, 2025

Arbutus Biopharma Corp (ABUS) With A Potential Upside Of More Than -139.44% - Stocksregister

May 01, 2025
pulisher
May 01, 2025

Arbutus Biopharma Corp (ABUS) looking to reclaim success with recent performance - Sete News

May 01, 2025
pulisher
May 01, 2025

Legal & General Group Plc Has $388,000 Stock Holdings in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

May 01, 2025
pulisher
Apr 30, 2025

Arbutus Biopharma Corp [ABUS] Insider Activity: An Update for Investors - knoxdaily.com

Apr 30, 2025
pulisher
Apr 28, 2025

Arbutus Biopharma Corp expected to post a loss of 10 cents a shareEarnings Preview - TradingView

Apr 28, 2025
pulisher
Apr 26, 2025

Stock Market Recap: Arbutus Biopharma Corp (ABUS) Concludes at 3.12, a -1.58 Surge/Decline - DWinneX

Apr 26, 2025
pulisher
Apr 25, 2025

Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Apr 25, 2025
pulisher
Apr 24, 2025

Will Arbutus Biopharma (ABUS) Report Negative Q1 Earnings? What You Should Know - Yahoo Finance

Apr 24, 2025
pulisher
Apr 24, 2025

Arbutus Biopharma Showcases Promising Hepatitis B Research at EASL Congress - MyChesCo

Apr 24, 2025
pulisher
Apr 23, 2025

Arbutus Biopharma Corp (ABUS)’s stock price in review: A technical analysis - uspostnews.com

Apr 23, 2025
pulisher
Apr 23, 2025

Arbutus to Present Imdusiran and AB-101 Data at EASL Congress 2025 - GlobeNewswire

Apr 23, 2025

Arbutus Biopharma Corp (ABUS) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
大文字化:     |  ボリューム (24 時間):